Related Experiment Video
Updated: Jun 10, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with
Zhen Qian1, Jun Qian, Jiang Lin
1Department of Hematology, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212002, China. qianjun0007@hotmail.com
Background:
GTPase regulator associated with the focal adhesion kinase (GRAF), a putative tumor suppressor gene, is found inactivated in hematopoietic malignancies by either genetic or epigenetic abnormalities. However, the expression level of GRAF gene has not yet been studied in leukemia. The aim of this study was to investigate the expression level of GRAF gene in those patients with myeloid malignancies including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and chronic myeloid leukemia (CML).
Methods:
The expression levels of GRAF transcript were determined in 94 patients using real-time quantitative PCR (RQ-PCR). Clinical and laboratory data of these patients were collected and analyzed.
Results:
The significantly decreased level of GRAF transcript was observed in three myeloid malignancies compared to controls. Within AML, there was no difference in the level of GRAF transcript among different FAB subtypes (P > 0.05). Difference was not observed in the amount of GRAF mRNA between CML at chronic phase and controls. As CML progressed, GRAF transcript significantly decreased. In MDS, three cases with 5q deletion had lower GRAF transcript than four without 5q deletion (median 0.76 vs 2.99) (P > 0.05).
Conclusion:
our results demonstrate that the GRAF transcript is decreased in myeloid malignancies.
Insights
The GTPase regulator associated with focal adhesion kinase (GRAF) transcript is significantly decreased in myeloid malignancies, including acute myeloid leukemia, myelodysplastic syndrome, and chronic myeloid leukemia. This suggests GRAF may play a role in these blood cancers.
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- GTPase regulator associated with focal adhesion kinase (GRAF) is a potential tumor suppressor gene.
- GRAF gene inactivation is observed in hematopoietic malignancies.
- GRAF gene expression levels in leukemia have not been previously studied.
Purpose of the Study:
- To investigate the expression level of the GRAF gene in patients with myeloid malignancies.
- To analyze GRAF gene expression in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and chronic myeloid leukemia (CML).
Main Methods:
- Quantitative real-time PCR (RQ-PCR) was used to determine GRAF transcript levels in 94 patients.
- Clinical and laboratory data were collected and analyzed.
Main Results:
- GRAF transcript levels were significantly decreased in AML, MDS, and CML compared to controls.
- No significant difference in GRAF transcript levels was found among AML FAB subtypes.
- GRAF transcript levels decreased as CML progressed.
- MDS cases with 5q deletion showed lower GRAF transcript levels.
Conclusions:
- The GRAF transcript is demonstrably decreased in myeloid malignancies.
- GRAF downregulation may be associated with the development or progression of these hematologic disorders.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
GTPases and their Regulation
Large G-proteins, also known...
GTPases and their Regulation
Large G-proteins, also known...
Amplifying Signals via Enzymatic Cascade
Activation and Inactivation of G Proteins

